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Abstract 
 
         In this study the incidence and determination of the prevalence rates of 
avian leucosis virus subgroup J (ALV-J) infectivity in Khartoum State, Sudan 
was achieved. This seems pretty important as the disease claimed to be 
responsible for many losses in poultry industry. Having the prevalence rates of 
the disease is known in Khartoum state, where an intensive poultry production 
is made, and strategic control program can be designed and implemented 
towards this important pathogen. 
 
         Serological investigation of ALV-J in commercial chicken farms in different 
areas in Khartoum state was done. An indirect ELISA system was adopted to 
detect the antibody (Ab) in chicken sera collected from the state. A total of 360 
serum samples were tested for the ALV-J (Ab) detection (325 layers and 35 
breeder layers). 
 
 
         An Ab response against ALV-J in 58 (17.84%) of the sera collected from 
the layers were proved positive to the virus infectivity and 2 (5.7%) in the sera 
of breeder layers.  
 
         The seroprevalence of ALV-J was compared in the different age groups of 
chicken flocks ranging from day one to 96- weeks. No obvious variations were 
noted.  
 
         Considering the geographical distribution of the virus, it was observed that 
the southern areas of Khartoum (Soba) had the highest rates of the virus anti- 
bodies distribution followed by Alkabashi and Aldoroshab areas in Khartoum 
north and the least virus antibodies distribution was observed in the western 
areas of Khartoum (Omdurman). 
 
iv 
 
The Ab responses against ALV-J were detected in both the commercial layers 
and breeder layers of chicken in different localities of Khartoum State without 
age susceptibility preference. The disease was seen to have higher rates in 
southern Khartoum followed by the north and lastly the west areas. The indirect 
ELISA system employed was proved efficient and practical to detect the Ab 
responses against ALV-J in chicken sera. 
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 اﻟﺨﻼﺻﺔ
 ﺗﺤﺖ sisocuel naivA ﻔﻴﺮوسﺑ اﻹﺻﺎﺑﺔ اﻧﺘﺸﺎر ﻣﻌﺪل وإﻳﺠﺎد ﺗﺤﺪﻳﺪ ﺗﻢ اﻟﺪراﺳﺔ هﺬﻩﻓﻲ 
 ﺗﺴﺒﺒﻪ ﻳﺒﻴﻦ آﻤﺮض آﺒﻴﺮة أهﻤﻴﺔ ﻳﻤﺜﻞ وهﺬا. اﻟﺴﻮدان اﻟﺨﺮﻃﻮم، ﺑﻮﻻﻳﺔ )J-VLA(J اﻟﻤﺠﻤﻮﻋﺔ
 اﻟﺨﺮﻃﻮم، وﻻﻳﺔ ﻓﻲ ﻣﻌﺮوف اﻟﻤﺮض اﻧﺘﺸﺎر ﻣﻌﺪل. اﻟﺪواﺟﻦ ﺻﻨﺎﻋﺔ ﻓﻲ اﻟﻔﻮاﻗﺪ ﻣﻦ اﻟﻌﺪﻳﺪ ﻓﻲ
 ﻋﻠﻰ ﻗﺪﻣﺎ وﺗﻄﺒﻴﻘﻬﺎ ﻜﻢﻟﻠﺘﺤ ﺑﺮﻧﺎﻣﺞ إﺳﺘﺮاﺗﻴﺠﻴﺔ ﺗﺼﻤﻴﻢ ﻳﻤﻜﻦ آﻤﺎ ﻟﻠﺪواﺟﻦ، اﻟﻤﻜﺜﻒ اﻹﻧﺘﺎج ﻳﺘﻢ ﺣﻴﺚ
  . اﻟﻤﻤﺮض اﻟﻔﻴﺮوس هﺬا
 اﻟﺪواﺟﻦ ﻣﺰارع ﻣﺨﺘﻠﻒ ﻓﻲ J-VLA اﻟﻀﺪ ﻋﻠﻰ واﺳﺘﻘﺼﺎء دراﺳﺔ إﺟﺮاء ﺗﻢ اﻟﻬﺪف، هﺬا وﻟﺘﺤﻘﻴﻖ
 ﻹﻳﺠﺎد اﻟﻤﺒﺎﺷﺮ ﻏﻴﺮ ASILE إﺧﺘﺒﺎر اﺳﺘﺨﺪم وﻗﺪ. اﻟﺨﺮﻃﻮم وﻻﻳﺔ ﻣﻦ ﻣﺨﺘﻠﻔﺔ ﻣﻨﺎﻃﻖ ﻓﻲ اﻟﺘﺠﺎرﻳﺔ
 063 اﺧﺘﺒﺎر ﺗﻢ. اﻟﻮﻻﻳﺔ ﻣﻦ ﺟﻤﻌﺖ اﻟﺘﻲ اﻟﺪﺟﺎج ﻋﻴﻨﺎت ﻓﻲ اﻟﻔﻴﺮوس ﺿﺪ( bA) اﻟﻤﻀﺎدة اﻷﺟﺴﺎم
  (. ﺗﺮﺑﻴﺔ ﺑﻴﺎض 53 و ﺑﻴﺎض 523) اﻟﻤﻀﺎدة اﻷﺟﺴﺎم ﻹﻳﺠﺎد ﻋﻴﻨﺔ
 و اﻟﺒﻴﺎض ﻣﻦ ﺟﻤﻌﺖﻋﻴﻨﺔ ﻣﺼﻞ %( 48.71) 85 ﻓﻲ J-VLA ﺿﺪ اﻟﻤﻀﺎدة اﻷﺟﺴﺎم وﺟﺪ ﻓﻲ
  . اﻟﺒﻴﺎض أﻣﻬﺎت ﻣﻦﻋﻴﻨﺔ ﻣﺼﻞ %( 7.5) 2 ﻓﻲ
 ﻓﻲ اﻷﻋﻤﺎر ﻣﺠﻤﻮﻋﺎت ﺑﻤﺨﺘﻠﻒ ﻌﻴﻨﺎتاﻟ ﻓﻲ J-VLA ﻔﻴﺮوسﻟ ﻣﻘﺎرﻧﺔ وﺟﻮد اﻷﺟﺴﺎم اﻟﻤﻀﺎدة  ﺗﻢ
  . آﺒﻴﺮة ﻓﺮوق ﻟﻢ ﺗﺴﺠﻞ. اﻟﺪراﺳﺔ هﺬا ﻓﻲ أﺳﺒﻮع 69 إﻟﻰ ﻳﻮم ﻋﻤﺮ ﻣﻦ اﻟﺪﺟﺎج
 اﻟﺠﻨﻮﺑﻴﺔ اﻟﻤﻨﺎﻃﻖ أن ﻣﻼﺣﻈﺔ ﺗﻢ ﻗﺪ ﻟﻠﻔﻴﺮوس،ﻻﻧﺘﺸﺎر اﻻﺟﺴﺎم اﻟﻤﻀﺎدة  اﻟﺠﻐﺮاﻓﻲﺑﺎﻟﻨﻈﺮ ﻟﻠﺘﻮزﻳﻊ 
 ﻓﻲ ﻓﺎﻟﺪروﺷﺎب ﻜﺒﺎﺷﻲاﻟ ﻣﻨﻄﻘﺔ ﺗﻠﺘﻬﺎ وﺟﻮد اﻷﺟﺴﺎم اﻟﻤﻀﺎدة ﻓﻲ اﻷﻋﻠﻰ هﻲ( ﺳﻮﺑﺎ) اﻟﺨﺮﻃﻮم ﻣﻦ
  .اﻟﺨﺮﻃﻮم ﻏﺮب  ﻓﻲ ﺗﺴﺠﻴﻠﻪ أو رﺻﺪﻩ ﺗﻢ ﻟﻠﻔﻴﺮوس اﻧﺘﺸﺎر ﻣﻌﺪل أﻗﻞ ﺑﺤﺮي، اﻟﺨﺮﻃﻮم
 ﻣﻦ اﻟﺪﺟﺎج ﻣﻦ اﻟﺘﺮﺑﻴﺔ وﺑﻴﺎض اﻟﺒﻴﺎض اﻟﻨﻮﻋﻴﻦ آﻼ ﻓﻲ ﺗﺤﺪﻳﺪهﺎ ﺗﻢ J-VLA ﻟــ اﻟﻤﻀﺎدة اﻷﺟﺴﺎم
 ﺑﺼﻮر اﻟﻤﺮض ﻳﻈﻬﺮ. ﻣﻌﻴﻦ ﻣﻘﺎرﻧﺔ اﻻﻋﻤﺎر ﻟﻴﺲ ﻟﺪﻳﻬﺎ ﺗﺄﺛﻴﺮ اﻟﺨﺮﻃﻮم وﻻﻳﺔ ﻣﻦ ﻣﺨﺘﻠﻔﺔ ﻣﺤﻠﻴﺎت
 ﻏﻴﺮ ASILE ﻧﻈﺎم ﺗﻄﺒﻴﻖ أﺛﺒﺖ. اﻟﻐﺮﺑﻴﺔ اﻟﻤﻨﺎﻃﻖ ﺛﻢ ﺑﺎﻟﺸﻤﺎل ﻣﺘﺒﻮﻋﺎ اﻟﺨﺮﻃﻮم ﺟﻨﻮب ﻓﻲ ﻋﺎﻟﻴﺔ
 . اﻟﺪﺟﺎج ﻋﻴﻨﺎت ﻓﻲ  J-VLA ﺿﺪ اﻟﻤﻀﺎدة اﻷﺟﺴﺎم اﺳﺘﺠﺎﺑﺔ ﻹﻳﺠﺎد ﻋﻤﻠﻴﺔ آﻔﺎءة اﻟﻤﺒﺎﺷﺮ
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Introduction 
 
         The leucosis / sarcoma (L/S) group of diseases designates a variety of 
transmissible and malignant neoplasm of chickens caused by members of the virus 
family termed as Retroviridae. Members of this group of avian viruses characterized 
by possession of the enzyme reverse transcriptase required for the virus replication 
which direct the synthesis of the proviral DNA life cycle. 
 
         These avian retroviruses include avian leucosis virus (ALV) and related 
viruses, formerly were placed in a subgenus termed avian type C oncorna viruses, 
(Matthews, 1982). But they recently have been termed as alpharetroviruses 
(Regenmortel, 2000). They are classified into subgroups A, B, C, D, E & J on the 
basis of envelope glycoproteins and interactions between viral specific cell 
receptors (Silva et al., 2000; Crittenden., 1981). 
 
         Lymphoid leucosis is the most common naturally occurring B- cell lymphoma 
of chickens caused by ALVS. Amongst those subgroups, A and B are the most 
prevalent and subgroup E is not pathogenic for poultry whereas subgroup J viruses 
are recombinant of exogenous and endogenous viruses (Alden, 1983). 
 
         In lymphoid leucosis, caused predominately by ALV subgroups A and B, the 
target cells for the transformation is primarily the B cells of the lymphoid lineage. In 
contrast, ALV subgroup J induces late onset of  myeloid leucosis targeting mainly 
the cells of the myeloid lineage (Venugopal, 1999). An exogenous ALV-J has been 
isolated form broiler chickens (Payne et al., 1991). Unlike exogenous ALV subgroup 
A, B, C, and D which induce lymphoid leucosis, that is tumor of the B cells derived 
from the bursa of fabricus, exogenous ALV – J induces myeloid leucosis which is 
the tumor of the myelomonocytic cell lineage (Arshad, 1998). 
 
         In addition to causing tumors, ALV-J can reduce productivity and may induce 
immunosuppression and other production problems in affected flocks of chickens 
(Arshad, 1998). ALV-J is transmitted vertical and horizontal transmission. It spreads 
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congenitally through the egg from infected hens to their chicks and to uninfected 
birds by contact from infected chickens or infected environment (Arshad, 1998) 
 
         In Sudan, avian leucosis complex was noticed during 1956 when exogenous 
poultry breeds were introduced for local stock improvement at the Research Division 
in the Ministry of Animal Recourses (MARF) in 1956 – 1960 (Anon, 1956). Analysis 
of available data showed that Marek's disease and lymphoid leucosis are of 
common occurrence in Sudan (Fawi et al., 1969; Omsalama, 2008). 
 
          Various methods have been used for the diagnosis of ALV infections to 
eradicate them from breeding units. This includes virus isolation, complement 
fixation test (CFT), PCR using the blood, organs and feather pulp (Smith et al, 1998 
Smith et al., 1998; Fadly and Smith, 1999; Zavala et al., 2002). ELISA is the most 
commonly used in diagnosis of ALV-J since it is sensitive, convenient and easy to 
perform (Wunaderwald et al, 2001; Wunaderwald et al., 2001; Zavala et al., 2002). 
 
Objectives:  
 
1. To determine the prevalence rates of ALV-J in Khartoum State, Sudan. 
2. To determine the age susceptibility preference of ALV-J in the layers 
chickens. 
3. To evaluate an indirect ELISA system for detection of antibodies against 
ALV-J from chicken sera under Sudan environment. 
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CHAPTER ONE 
Literature Review 
 
1-1 The virus 
          Avian leukosis viruses (AVLs) are members of the family Retroviridae and are 
associated with a variety of neoplasm and production problems in chickens. They 
are classified into subgroups A, B, C, D, E and J. 
         ALV-J infection was first reported in the United Kingdom in 1991 in meat type 
of chicken. Exogenous ALV-J induces myeloid leucosis which is the tumor of the 
myelomonocytic cell lineage. Besides causing tumor, ALV-J reduces productivity 
and may induce immune suppression and other production problems. 
 
1-1-1 Classification  
         Viruses of avian leucosis / sarcoma group are placed, in a new classification 
of the International committee on taxonomy of Viruses (ICTV), in the Alpha-
retrovirus genus of the family Retroviridae (Regenmortal et al., 2000).  
Members of this family are RNA viruses characterized by the possession of the 
enzyme reverse transcriptase, which is necessary for the formation of a DNA 
provirus that is integrated in the host genome during virus replication.  
         Under the new taxonomy, avian leukosis virus (ALV) is the type species of the 
genus. Other species in the genus are Rous Sarcoma virus (RSV) and a number of 
replication defective viruses carrying various oncogenes.  
 
1-1-2 Morphology  
Avian leucosis/ sarcoma viruses (ALSV) have an inner, centrally located electron– 
dense core about 35 – 45 nm in diameter, an intermediate membrane, and an outer 
membrane. This appearance typifies the C type retroviral morphology. The over all 
diameter of the virus particle is 80– 120nm, with an average 90nm– immature 
virions budding from the cell membrane can be visualized. Negatively stained 
preparations reveal essentially spherical particle that are readily destroyed under 
certain conditions of drying (Beard, 1973). Characteristic knobbed spikes about 8nm 
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in diameter are present on the surface of the particle and comprise the viral 
envelope glycoproteins.  
 
1-1-3 Strain differentiation 
1-1-3-1 Antigenicity  
 Avian leucosis viruses (ALVs) those occur in chickens have been divided into 
6 subgroups, A, B, C, D, E and J on the basis of differences in their viral envelope 
glycoprotein's, which determine antigenicity, viral interference patterns with 
members of the same and different subgroups, and host range in chicken embryo 
fibroblasts of different phenotypes (Weiss et al., 1982). The other subgroups, F, G, 
H, and I represent an endogenous ALVs occurring in pheasants, partridge and quail 
(Payne, 1992). Viral interference patterns and host range patterns are the most 
reliable methods for subgroup classification.  
Antigenicity, as determined by the production of neutralizing antibodies or 
neutralization by known subgroup – specific antibodies, can also be used for strain 
classification but is less dependable.  
Viruses within asubgroup usually cross neutralize to varying extents but with 
the exception of partial cross neutralization between subgroup B and D viruses, 
viruses of different groups do not.  
Anti sera against particular isolates of subgroup J virus do not always cross 
neutralize other J isolates, or they may show one – way cross – neutralization. 
(Gilka and Spencer, 1987; Venugopal et al., 1998; Fadly et al., 2000). Generally, 
antiserum raised against a particular strain of virus tends to neutralize the 
homologous virus more strongly than heterologous virus of the same subgroup 
(Chubb and Biggs, 1968). These findings indicate the presence of varying antigenic 
epitopes within subgroups. Subgroup B viruses appear to be more heterogeneous 
than those of subgroup A, and subgroup J viruses are especially variable.  
 
1-1-3-2 Molecular characteristics  
 Sequence analysis of the gp85 encoding sequences of the envelope genes of 
ALVs of subgroups A-E have identified 2 hypervariable regions, hr1 and hr2 and 
Three less variable regions, vr1, vr2, and vr3, in which differences between 
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subgroups are present (Droner et al., 1985; Bova et al., 1986;). Studies of 
recombinant indicated that hr1 and hr2, and to a lesser extent vr3, play the major 
role in determining receptor tropism ( Dorner and Coffin, 1986)  
However, the exact locations and nature of the differences that determine host 
range and antigenicity have not yet been identified.  
The gp85 sequence of envelop gene of subgroup J ALVs differ more 
extensively from those of the other 5 subgroups, notably at hr1, hr2, vr2, and vr3, 
and to a lesser extent also between these regions (Bai et al., 1995)  
different subgroup J isolates also vary at particular hyper variable regions of 
gp85. (Venugopal et al., 1997; Benson et al., 1998; Silva et al., 2000) 
 
1-1-4 Physico chemical properties 
 Avian retroviruses have a high lipid content in the envelope, and their 
infectivity is abloished by ethyl ether (Friesen and Rubin,1961). The detergent 
sodium dodecyl sulfate (SDS) disrupts the virions and releases RNA and core 
proteins (Robinson and Duesberg, 1968 ) 
The half–life of various ALSVs at 37oC varies from 100–540 minutes, 
depending on the medium in which the virus is suspended, the tissue of origin, and 
the virus strain (Vogt, 1965). ALSVs inactivated rapidly at high temperature. Thermal 
liability of infectivity of these viruses is a critical factor in storage it is only at 
temperatures below – 60oC that avian retroviruses can be stored for several years 
without losing of infectivity (Bryan et al., 1954).  
The stability of viruses of this group changes little between pH 5 and pHs 9 out 
this range in activation rates are markedly increased.  
Field strains of ALV are relatively resistant to exposure to ultraviolet light 
(Rubin, 1960; Friesen and Rubin., 1961)  
 
1-1-5 Viral proteins 
 The virion core contain 5 non–glycosylated proteins encoded by the gag/pro 
gene: MA (matrix p19); pl0, CA (Capsid, p27), which is the major gs antigen (Gag) 
in the core shell; NC (nucleo capsid, p12) involved in RNA processing and 
packaging; and PR (protease, p15), involved in cleavage of protein precursors. The 
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pol gene encodes the enzyme reverse transcriptase (RT) present in the core. It is a 
complex consisting of the  subunit and  subunit derived from it and has RNA and 
DNA – dependent polymerase and DNA: RNA hybrid – specific ribonuclease H 
activities.  
The  subunit also contains the IN domain (integrase, p32), the enzyme 
necessary for integration of viral DNA into the host genome. (Weiss et al., 1985) 
The virion envelope contains 2 glycoprotein's encoded by the envelope gene: 
SU (surface, gp85), the viral surface knob – like structures that determine viral 
envelop subgroup specificity of the ALSV; and TM ( transmembrane, gp37) 
representing the transmembrane structure that attaches the knops to the envelope. 
These 2 envelope proteins are linked to form admire, termed virion glycoprotein 
(VGP) (Weiss et al., 1985).  
Enzymes and other proteins are found in virion and considered to be cellular 
components incorporate during virus maturation (Temin, 1974). 
 
1-1-6 Virus replication  
 Great effort has been made to elucidate replication events details of which are 
discussed by Luciw and Leung (1992) and Coffin et al. (1997). Although adsorption 
of the virion to the cell membrane is non specific, occurring even in cells membrane 
resistant to infection (Piraino., 1967).  
Penetration of cells dependent on the presence, in the cells membrane, of host 
gene – encoded respecters specific for particular virus envelope subgroups and on 
fusion of viral and cell membranes.  
Binding of the virus to the receptor (For subgroup A ALV at least) triggers a 
conformational change in the viral envelope glycoprotein that allows viral fusion with 
the cell membrane and viral entry (Gilbert et al., 1995).  
Major stages in formation of retroviral DNA are start by synthesis of the first 
(minus) strand of viral DNA by reverse transcription of viral RNA by reverse 
transcriptase, forming an RNA: DNA hybrid; removal of RNA from the hybrid by 
RNase – H and formation on the template of minus – strand DNA of second (plus) 
strand of viral DNA, giving rise to linear DNA duplexes; and migration of linear DNA 
to the cell nucleus.  
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Linear viral DNA becomes linearly integrated into the host DNA under the 
influence of the enzyme integrase.  
This integration can occur at many sites, and infected cells can contain up to 
20 copies of viral DNA. The pro viral gene occur in the same order as their RNA 
copies occur in the virion, and they are flanked on either side by identical 
sequences of nucleotides – the long terminal repeats (LTRs ).  
These are composed of repeated sequences derived from terminal regions of 
viral RNA and include promoter and enhancer sequences controlling transcription of 
viral DNA to RNA.  
The LTR promoters may also cause abnormal transcription of host gene 
usually down stream of the pro viral DNA, leading to oncogenesis.  
Formation of anew virions in the infected cells is the result of transcription and 
translation of pro viral DNA.  
Transcription of the sequence of the gag/pro gene to produce protease (PR) 
involves a frame shift viral RNA molecules give rise to m RNA in association with 
poly ribosome's, and they also serve as genomic RNA in newly formed virions.  
m RNA species, bound to poly ribosome's, are translate to form the gag, pol, 
and env gene – coded proteins that compose the virion.  
The gag – pol gene product is a large protein precursor pr180 which is cleaved 
to give a precursor poly protein pr76 From which virion core protein MA matrix 
(P19), CA capsid (P27), NC nucleocapsid (P12) PR protease (P15) and P10 are 
derived.  
The env gene product is a precursor protein gpr92 From which the viral 
envelop protein SU (gp85 surface) and TM (gp37 trans - membrane are derived.  
The viral proteins localize at the plasma membrane of the cell and developed 
into virion budded off from the cell.  
 
1-2 The disease  
1-2-1 Incidence and Distribution  
 ALVs are still considered ubiquitous in commercial chicken. With few 
exceptions, infection occurs in all chicken flock and most birds with in a flock are 
already exposed.  
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Al though sporadic cases of ALV – induced neoplasm occur in most flock, it is 
only occasionally that even the most common neoplasm, lymphoid leukosis, 
produces heavy losses – (Fadly and Crittenden, 1987; Payne and Fadly, 1997; 
Payne and Venugopal, 2000).  
The incidence of LL in chickens may be reduced by the wide spread 
occurrence of infectious bursal disease virus (Purchace and Cheville., 1975; 
Crittenden and Witter., 1978).  
Conversely, serotype 2 of the Marek's disease virus (MDV) was found to 
enhance the development of LL in certain lines of chickens following exposure to 
ALV after hatch (Bacon et al., 1989; Fadly 1992; Fadly and Witter, 1993; Fadly and 
Ewert, 1994).  
Also Salter et al. (1999 reported an increased frequency of spontaneous bursal 
lymphoma (Crittenden et al., 1979) in white leg horn chickens inoculated with 
serotype 2 MDV.  
In vitro studies also showed that serotype 2 of MDV can increase ALV as well 
as RSV gene expression (Tieber et al., 1990; Pulaski et al., 1992; Banders and 
Cossens, 1994).  
Very few report have been, made of natural occurrence of myeloblastosis but 
cases occur sporadically. Until recently and before the recognition of subgroup J 
ALV (Payne et al., 1991; Payne and Venugopal, 2000), myelocytomatosis was 
mainly a sporadic disease seen among young and adult birds (Purchase et al., 
1972). 
 An over – all incidence of 27% myelocytomatosis was reported in meat – type 
chickens inoculated with strain HPRS – 103 of ALV-J (Payne et al., 1992 ).  
Up to 1.5% in excess of normal mortality per week was reported in commercial 
broiler breeder flocks naturally infected with ALV-J (Fadly and Smith, 1999). 
Antibodies to the novel subgroup J ALV were found in 3 of 5 meat, type 
chicken lines but not in 7 layer lines examined in united kingdom (Payne et al., 
1985). Using virological and serological assays, the incidence of ALV-J infection in 
affected broiler breeder flocks was reported to be as high as 87% (Fadly and Smith., 
1999).  
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1-2-2 Transmission  
Exogenous ALVs are transmitted in two ways vertically from hen to progeny 
through the egg and horizontally from bird to bird by direct contact (Cottral et al., 
1954; Rubin et al., 1961; Rubin et al., 1962). Most chickens became infected by 
close contact with congenitally infected birds.  
Although vertical transmission is important in the maintenance of the infection, 
horizontal infection may also be necessary to maintain a rate of vertical transmission 
sufficient to prevent the infection from dying out (Payne and Bumstead., 1982).  
The infection does not spread readily from infected birds to bird in indirect 
connect probably because of the relatively short life of the virus out side the birds.  
However, contact exposure at hatch was shown to be an effective method of 
spread of ALV-J among broiler breeder chickens (Fadly and Smith., 1999; Witter., 
2000; Witter et al., 2001), and was prevented by small group rearing (Writter and 
Fadly., 2001).  
Four classes of ALV infection are recognized in mature chickens the first class 
no viremia no antibodies (V-A-), second class no viremia with antibodies (V-A+), third 
class with viremia with antibodies (V+A+), fourth class with viremia no antibodies 
(V+A-), (Rubin et al., 1961; Rubin et al., 1962). Birds in an infection free flock and 
genetically resistant birds in susceptible flock fall into the category V-A-. Genetically 
susceptible birds in an infected flock fall into one of the other three categories. Most 
are V-A+, and a minority usually less than 10% are V+A-. Most V+A- hens transmit 
ALV to a varying but relative high proportion of their progeny (Rubin et al., 1962; 
Payne et al., 1982). 
Small proportion of V-A+ hens transmit the virus congenitally and do so more 
intermittently, the tendency for congenital transmission of ALV in this category was 
found to be more frequent in hens with low antibody titer (Tsukamoto et al., 1992). 
Congenitally infected embryos develop immunologic tolerance to the virus and 
after hatching make up the V+A- class with high levels of virus in the blood and 
tissues and absence of antibodies. By 22 week of age, up to 25% of meat type 
chickens exposed to ALV-J at hatch were found to be V+ A- (Fadly and Smith., 
1999). The genetics of the host and the strain of ALV influence shedding and 
congenital transmission after horizontal infection (Crittenden et al., 1984).  
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Older hens (2or 3 year of age) transmit virus in their eggs less consistently and 
at a lower level than birds under 18 months (Burmester and Walter., 1961) 
The rule of males in transmission of ALV is equivocal. Infection of the cock 
apparently does not influence the rate of congenital infection of progeny (Rubin et 
al., 1961; Spencer et al., 1980). 
With electron microscopy, the virus budding has been seen on all structures of 
reproductive organs of cocks except germinal cells (Distefano and Dougherty., 
1966). 
The cock acts only as a virus carrier and source of contact of venereal 
infection to other birds (Smith et al., 1979; Spencer et al., 1980).  
Congenital infection of embryos is strongly associated with shedding by the 
hen of ALV into egg albumen and with presence of virus in the vagina of hens 
(Spencer et al., 1977; Payne et al., 1982).  
Electron microscopy studies have revealed a high degree of virus replication in 
the magnum of the oviduct (Distefano and Dougherty., 1966). 
Infection virus is also present in saliva and feces of older bride that provide a 
source of horizontal infection to other brides (Burmester., 1956). 
 
1-2-3 Incubation period  
Members of the L/S group of viruses are multipotent viruses capable of inducing a 
variety of neoplastic diseases. The incubation period for these diseases is 
dependent on strain and dose of virus, route and age at exposure and genetic 
constitution of the host. Susceptible chicks inoculated as embryos or at 1–14 days 
of age with a strand strain of ALV – RPL 12 (Burmester et al., 1959) B15, F42 
(Biggs and Payne., 1964) or RAV1, developed LL between 14 – 30 of age. It is very 
seldom that LL occur in chickens under 14 weeks.  
Certain laboratory recombinant viruses have been shown to cause LL with in 5 
– 7 weeks (Kanter et al., 1988), although such short incubation periods are not 
found in field out break 
Another determining factor is whether virus strain lack or possess a viral 
oncogene, for example disease such as Erythroblastosis induced by slowly 
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transforming viruses lacking oncogene, usually develop after along latent period 
(Fung et al., 1983)  
Field strains and viruses passaged in cell culture induce erythroblastosis after 
a longer incubation period (Burmester and Fredrickson, 1964). Virus induced 
mylocytomatosis generally has a longer incubation period than erythroblasfoeis and 
myelobastosis induced by the acutely transforming virus strains, but shorter than LL. 
on IV injection of MC29 into young chicks, myelocytomas were obtained in 3 – 11 
weeks (Mladenov et al., 1967). 
The incubation period in field cases is unknown, but most cases are observed 
in immature birds.  
Myelocytomatoeis induced by the HPRS – 103 strain of ALV, which lacks a 
viral oncogene, had along latent period (Payne et al., 1992). 
Median time to death with the a cutely transforming 879 strain variant of HPRS 
-103, believed to carry a viral oncogene was 9 weeks (Payne et al., 1993).  
Field cases of subgroup – J induced myelocytomatosis were reported in broiler 
breeder chickens as young as 4 weeks of age (Fadly and Smith., 1999). 
 
1-2-4 Clinical signs 
Out word sings of the leukotic disease are mostly nonspecific – they include in 
appetence, weakness, diarrhea, dehydration, and emaciation. In myelocytomatosis, 
skeletal myelocytomas may cause protuberance on the head, thorax, and 
shanks.Myelocytomas may occur in the orbit of the eye, causing hemorrhage and 
blindness. 
 
1-2-5 Lesions 
Tumors of myelocytomatosis characteristically, they occur on the surface of 
bones in association with the preiosteum and near cartilage, although any tissue or 
organ can be affected.  
Myelocytomas often develop at the costochondral junctions of the ribs, on the 
inner sternum, pelvis, and on the cartilaginous bones of the mandible and nares flat 
bones of the skull are also commonly affected tumors may also be seen in the oral 
cavity, trachea, and around the eye (Pope et al., 1999).  
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The tumors are usually nodular and multiple, with soft, friable consistency and 
of creamy color. In the disease caused by subgroup J ALV, myelo -cytomatosis 
infiltration often causes enlargement of the liver and spleen and other organs in 
addition to skeletal tumors. myelocytic leukemia occur ( Payne et al., 1991).  
 
1-2-6 Histopathology  
 Tumors consist of masses of uniform, usually well differentiated, myelocytes. 
Their nuclei are large vesicular, and usually eccentrically located, and a distinct 
nucleolus is usually present. The cytoplasm is usually tightly packed with acidophilic 
granules. Areas of less differentiated myelocytes are not uncommon within the 
myelocytomas, and areas of undifferentiated cells, which may be stem cells of the 
myelocytemonocyte series, may also be found.  
In the liver, accumulations of neoplastic myelocytes occur around blood 
vessels and in the parenchyma. In the spleen, tumor cells are present in the red 
pulp. in the marrow the extra sinusoidal myelopoietic areas are greatly expanded by 
uniform neoplastic myelocytes (Nakamura et al., 2000). 
Ultra structural features of myelocytoma cells vary from those of well 
differentiated myilocytes to those of undifferentiated, non-granulated myeloid cells 
(Mladenov et al., 1967) 
 
1-2-7 Pathogenesis  
Acutely transforming strains of ALV that induce myelocytomatosis, such as 
MC29 and CM11, carry the V- myc oncogene (Enrietto and Hayman, 1987; 
Moscovici and Gazzolo., 1987). Slowly transforming strains of subgroup J ALV that 
also induce myeloctomatosis, such as HPRS – 103 and ADOL – Hcl do not carry an 
oncogene, but moleculer studies of HPRS – 103 induced myelocytomatosis indicat 
that C – myc is activated (Chesters et al., 2001) 
The acutely transforming strain 966 ALV, derived from myelocytoma and 
induced by strain HPRS – 103 of subgroup J ALV, has been shown to carry V- myc 
(Payne et al., 1993; Chesters et al., 2001). 
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Studies on HPRS – 103 and 966 showed that they have a tropism for the 
myelomonocytic cell lineage, which may relate to their ability to cause 
myelocytomas (Arshad et al., 1997; Arshad et al., 1999).  
The earliest alterations occur in bone marrow in which there is crowding of 
intrasinusoidal spaces, principally by myelocytes, and destruction of sinusoid walls. 
The spaces may contain 2 type of cell – myeloidstemcell and the neo plastic 
myelocyte. The later appears to arise directly from the stem cell, and differentiation 
is arrested both at the non granulated and granulated myelocyte level (Mladenov et 
al., 1967).  
Renal adenomas and carcinomas can be caused by solely and acutely 
transforming subgroup J ALV (Payne et al., 1992; Pyne et al., 1993). 
Hemangiosarcomas have been associated with subgroup J ALV infection 
(Payne., 2000). 
 
1-2-8 Immunity  
1-8-8-1 Active immunity  
  Under natural conditions, most chicken become infected by exogenous ALV 
from pen mates or their surroundings and, after a transient viremia, develop virus 
neutralizing antibodies directed against virus envelope anti gene that rise to a high 
titer and persist throughout the life of the bird (Rubin et al., 1962; Solomon et al., 
1966). 
After inoculation of birds with ALV at 4 weeks of age or older, transient viremia 
was detectable at 1 week and was following by antibodies at 3 weeks and later 
(Maas et al., 1982). 
In study of birds naturally infected after hatching, antibodies were first detected 
at 9 week of age, with marked increase in the proportion with antibodies between 14 
and 18 weeks, when 80% were positive (Rubin et al., 1962).  
Knowledge of the occurrence of, and the role played by cell–mediated 
immunity (CMI) in ALSV infection is still incomplete, but it is likely to be directed 
against both the virus infection and tumor formation.  
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The presence of cytotoxic lymphocytes against viral envelope anti gene has 
been showing birds immunized with ALV or RSV (Bauer et al., 1976; Bauer and 
Fleischer, 1981) 
Chicken that are infected congenitally by ALV do not develop immune 
responses to the virus.  
Instead, they become immunologically tolerant to the virus and develop a 
persistent viremia in the absence of neutralizing antibodies (Rubin et al., 1962; 
Meyers, 1976). 
Infection with subgroup J ALV is particularly likely to induce a tolerant infection 
(Fadly and Smith., 1999; Witter., 2000; Witter et al., 2001 ). 
 
Infection by ALV can depress primary and secondary antibodies responses and cell 
– mediated immunity (Rup et al., 1982).  
In a study of congenital infection with an A subgroup ALV, RAV -1, failed to 
detect effects on B and T-cell function during the early and late stages of infection, 
and they reported no histological damage to the bursa, thymus or spleen.  
In contrast, subgroup B ALVs have been to induce a marked suppression of 
the humoral immune response to several antigens and decreased responsiveness 
to several mitogens (Watts and Smith., 1980) 
Evidence that subgroup J ALV is immuno suppressive appears to be equivocal 
at present (Smith et al., 1998; Stedman et al., 2000).  
 
1-2-8-2 Passive Immunity  
Serum antibodies, which are mainly in the IgG fraction (Meyers and 
Dougherty., 1972), are passed on by the hen to her progeny via the egg yolk and 
provide passive immunity that lasts 3-4 weeks.  
Passive antibodies delay infection by ALV (Witter et al., 1966), reduces the 
incidence of viremia and shedding of ALV (Fadly., 1988) and reduce the incidence 
of tumors (Burmester., 1955).  
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1-3 Diagnosis:  
 1-3-1 Isolation and identification of causative a gent:  
 Sample most commonly used for detection of ALV include blood, plasma, 
serum, meconium, cloacal and vaginal swabs, oral washing, eggs albumen, 
embryos and tumors (Burmester., 1956; Rubin et al., 1961; Spencer et al., 1977 
Grittenden and smith 1984.; Fadly et al., 1981; Fadly and Witter., 1998; Fadly., 
2000;).  
Virus also can be isolated from albumen of newly laid eggs or the 10 – day – 
old embryo of eggs laid by hens that are transmitting virus vertically (Spencer. 
1987), from feather pulp (Spenser et al., 1983) and from semen.  
All ALSVs are very thermolabile and can be preserved for long periods only at 
temperatures below – 60oc – thus, materials used for biological assay for infection 
virus should be collected and placed on melting ice or stored at – 70o c until 
assayed in contrast, sample for detection of ALV antigens by direct assays can be 
stored at – 20o c (Fadly and Witter., 1998).  
Because most strains of ALV produce no visible morphologic changes in cell 
culture assays for ALV are based on detection of specific proteins or glycoprotein 
coded by I or more of the 3 major genes of ALV namely gag, pol, and env genes, or 
detection of specific pro viral DNA or viral RNA sequences of ALV by the 
polymerase chain reaction and reverse- transcription (RT) – PCR, respectively.  
The presence of virus is determined by the detection ALV P27 by indirect 
biologic assays. Such as complement fixation  
For avian leukosis (COFAL) (Sarma et al., 1964), ELISA for ALV (Crittenden et 
al., 1987; Fadly and Witter., 1998) 
Phenotypic mixing (Okazakie et al., 1975), resistance inducing Factor (Rubin., 
1960), and non producer cell activation (Rispens et al., 1970). 
Of all such assays, ELISA – ALV is the most commonly used test.  
 
1-3-1-1 Resistance – Inducing Factor Test:  
In general, most ALVs do not induce alteration in cultural cells except after 
prolonged passage (Calnek., 1968). When CEFs are infected with an ALV, they 
become resistant to super infection by a sarcoma virus of the same subgroup. Only 
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viruses of the same subgroup interfere with one another in this way. The property of 
interference has been used for assay of ALV by the RIF test and also in delineating 
virus subgroup (Vogt and Ishizaki., 1966). 
In the RIF test, known susceptible chicken embryo fibroblast cultures are 
inoculated with material suspected of containing an ALV. Cells are sub cultured at 
least 3 times at 3 – 4 day intervals, and at each passage, a sample of the cells is 
testes for susceptibility to RSVs of different subgroups. Alternatively, supernatant 
fluids may be transferred to new cell culture every 4days.  
In this case, cells may be challenged without subculture 4 – 6 days post 
inoculation control cultures infected with known ALVs and uninfected cultures are 
always included o establish validity of the tests.  
Presence of ALV in a cell culture is indicated by a 10 – fold or greater 
reduction in number of foci produced by a standard stick of RSV when compared 
with the number of foci on similarly challenged control cells. Several different 
challenged viruses, one for each subgroup, must be used to detect ALVs belonging 
to different subgroups each requires a separate cell culture plate for testing.  
 
1-3-1-2 Detection of the viral internal group specific Antigens: 
Detection of the major antigens P27 present in the core of ALVs forms the 
bases of several diagnostic tests for virus. The COFAL test can be used to detect 
the gs antigen in cultures of fibroblasts that have been inoculated with virus (Sarma 
et al., 1964). 
Cells must be susceptible to the infection with the virus sought, to obtain a 
suitable antigen from low titer inoculate, inoculated Fibroblasts must be cultivated 
for 14 days before they are harvested.  
The harvested cells are adjusted to a standard concentration, frozen, thawed, 
and used as antigen in the test.  
Various controls are necessary, including un inoculated fibroblasts, because 
these may contain gs antigen derived from endogenous ALV.  
Titration of complement – fixing of extracts of the control and inoculated 
cultures allows differential between endogenous and exogenous viral antigen, 
because the titer of the latter is much higher. 
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Complement fixing anti serum against gs antigen can be obtained from 
hamsters bearing sarcomas induced by RSV (Sarma et al., 1964). 
Rabbit and other mammalian antiserums prepared against purified gs antigens 
derived from avian myeloblastosis virus can also be used (Stephenson et al., 1973; 
Stephenson et al., 1975).  
Highly sensitive radioimmunoassay (Estola et al., 1974; Sandelin, 1974), and 
ELISA tests (Smith et al., 1979; Clark and Dougherty., 1980) for gs antigens have 
been developed these antigens may also be detected in cells by FA techniques 
(Kelloff and Vogt., 1966; Payne et al., 1966).  
Using indirect FA tests, mono clonal antibodies to ALV-J proved useful in the 
detection of ALV-J infected cell cultures (Venugopal et al., 1997; Fadly et al., 2000; 
Qin et al., 2001).  
 
1-3-1-3 Tests based on phenotypic mixing of viruses 
CEFs can be infected with envelope detective strains of RSV (eg, BH – RSV) to 
produce transformed cells that are non producers of infection RSV subgroup A, B, 
and D. Super infection of a culture of NP cells by a leukosis helper virus results in 
production of RSV, which is detectable in supernatant fluid by assays in susceptible 
CEF cultures and forms the basis of the NP cell activation test (Rispens et al., 
1970). Non producer cells form embryos with endogenous subgroup E ALV may 
spontaneously produce a subgroup E RSV form complementation of the defective 
RSV subgroup E envelope.  
In assaying for RSV production, it is then necessary to use fibroblast cultures 
resistant to subgroup E but susceptible to subgroup A, B, C, D and J (C/E cells ). A 
useful modified NP cell activation test uses Japanese quail cells that have been 
transformed with envelop defective BH – RSV. Those non producing R (-) Q cells 
can be activated to produce infectious RSV by cultivation with C/E cells infected 
with exogenous ALV under test, thus providing the R (-) Q test (Crittenden et al., 
1979).  
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1-3-1-4 Enzyme assays  
Assays for RT activities have been used for the detection of oncogenic RNA 
viruses including all ALSVs (Temin, 1974). Detection of this enzyme, either directly 
when the correct template is used (Kelloff et al., 1972; Tereba and Murti., 1977) or 
indirectly when the radioimmunoassay is used (Panet et al., 1975), is an indication 
of presence of virus.  
Most recently, a highly sensitive PCR – based RT assay has been used to 
screen human vaccines that are product in CEF or embryonated eggs for freedom 
from avian retroviruses (Tsang et al., 1999). In all tests for detection of ALV by RT 
assay, control tests must be conducted to rule out the presence of RT and of other 
retroviruses.  
 
1-3-1-5 Detection of viral nucleic acids 
 Blot hybridization analysis of viral DNA or RNA in cell extracts is used 
increasingly for the detection of virus in avian tumor virus research (Weiss et al., 
1982; Weiss et al., 1985). The PCR is the most common DNA – based test used for 
detection and identification of ALV including subgroup E virus – RT – PCR has also 
been used to detect several subgroups of ALV (Hauptli et al., 1997). 
 Several primers specific for the detection of the most commonly isolated ALVs, 
particularly subgroup a (Lupiani et al., 2000), and new subgroup ALV-J (Smith et al., 
1998; Silva et al., 2000) have been developed.  
 
1-3-1-6 Hematopoietic Transformation  
Assays usually are based on a quantal response in which individual cultures 
are scored as positive or negative (Mocovici., 1975; Baluda., 1963). Focus assays 
for myeloblastosis, erythroblastosis, and other defective ALVs have been developed 
(Graf., 1975; Moscovici et al., 1975; Graf et al., 1978).  
Cultured chicken bone – marrow cell and blood monocytes are useful in 
isolation and propagation of acutely cases of myeloid leucosis induced by strain 
HPRS – 103 ALV-J (Payne et al., 1992). 
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1-3-2 Serology 
Suitable samples for detection of antibodies to ALVs are plasma, serum or egg 
yolk. Antibodies to ALV can be measured by its reaction with RSV or ALV, a virus of 
one group will not be neutralized by antibodies provoked by a virus of a different 
subgroup (Vogt and lshizaki., 1966) usually, a 1:5 dilution of heat – inactivated 
serum is mixed with an equal quantity of a standard preparation of RSV of a known 
pseudo type, after inoculation, the residual virus is quantitated by any one of many 
procedures, the cell culture assay being most commonly used (Rubin et al., 1962).  
A micro- neutralization test to assay for residual virus can used for detection of 
ALV antibodies (Fadly and Witter., 1998) the test can be conducted in 96 – well 
micro titer plates, and the neutralization of the virus is determined by an ELISA on 
culture fluids (Fadly et al., 1989).  
An indirect immunoperoxidase absorbance test (Mizuno and Hatakeyama., 
1983) ELISA tests (; Tsukamoto et al., 1985; Mizuno and Itohara., 1986; Smith et 
al., 1986; Tsukamoto et al 1991) and flowcytometry (Hunt et al., 1999; Hunt et al., 
2000) have been described for the detection of antibodies.  
Molecularly cloned, baculovirus – expressed envelope glycoproteins of ALV-J 
now are being used in commercial ELISA kits specific for detection of antibody to 
ALV-J (Venugopal et al., 1997; Lee et al., 2000;).  
 
1-3-3 Serotyping of ALV 
Based on host range, interference spectrum, and viral envelop antigens, 
viruses of L / S group occurring in the chickens are divided into 6 subgroup A, 
B.C.D, E and J (Crittenden., 1981; Weiss et al., 1982; Payne et al., 1991). No 
common neutralization antigens are among the viruses of different subgroups, 
except for relation ship between subgroup B and D. The diagnosis of infection by 
serologic means requires that representatives of all serotype be employed – ALVs 
them selves may be used, but more commonly, RSV, pseudo types are employed in 
the neutralization tests (Fadly and Witter., 1998).  
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1-4Differential diagnosis  
The distinctive character and location of tumor provide the basis for diagnosis, 
which can be verified by examination of a stained smear or tumor section. Gross 
tumor must be differentiated from myeloblastosis, LL, osteopetrosis and necrotic 
and / or purulent processes occurring in tuberculosis, pullorum disease and mycotic 
infections. in recent out breaks of ALV-J induced tumors, myelocytomatosis was 
diagnosed primarily on the basis of presence of characteristic microscope feature of 
tumor cells (Payne et al., 1991; Payne and Fadly., 1997; Payne and Venugopal., 
2000).  
 
1-5 Control  
1-5-1 Vaccination  
 No commercial vaccine is available for the protection of chickens from ALV – 
infection. In a series of attempts to inactivate ALV by various means, however 
Bermester 1968 demonstrated that ability of these virus preparations to induce 
antibody was destroyed almost concurrently with inactivation. Attempts to produce 
attenuated strains of ALV that do not induce disease have also failed (Okazaki et 
al., 1982).  
Some success has been obtained in attempts to increase the resistance of the 
host to RSV by immunization with viral or cellular antigens (Payne., 1981; Bennett 
and Wright., 1987).  
The use of experimental recombinant ALVs vaccines may prove to be a 
valuable to current programs for reduction or eradication of ALV infection.  
Recombinant ALVs expressing subgroup A (Mc Bride and Shuman., 1988; 
Chebloune et al., 1991; Fadly., 1992; Wright and Bennett., 1992) and ALV-J 
(Venugopal et al., 1997; Lee et al., 2000), envelope glycol proteins have been 
produced that could have potential as vaccines to protect against horizontal 
transmission.  
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1-5-2 Treatment 
No practical measures have been found for treatment of the various forms of 
avian leukosis complex, all attempts to treat virus – induced neoplasia have resulted 
in negative results.  
 
1-5-3 Eradication  
Eradicating of ALV from primary breeding stock is the most effective means for 
controlling ALV infection in chickens.  
Until 1977, eradication was only applicable to experimental or special flocks 
because methods used were long, complicated, and expensive. Since then, 
eradication from commercial flocks has become feasible (Chase, 1991; Payne and 
Howes., 1991; Payne and Fadly., 1997; Spencer., 1997; Witter and Fadly., 2001) 
using the techniques of (Spacer et al., 1977).  
Programs of eradication of ALV infection depends on breaking the vertical 
transmission of virus from dam to progeny. Breeder hens are tested by various 
methods for the presence of ALV, and those that test positive are discarded.  
In order to establish an ALV – free flock, it is necessary to hatch, rear, and 
maintain in isolation a group of chickens free from congenital infection .To achieve 
this, embryos must be obtained from dams that are not transmitting virus to their 
progeny. The dams selected to produce the next generation and hoped to be virus 
free generation were:  
1.  Immune, non virus shedder hens with antibodies were selected on the 
assumption that they were less likely than hens with out antibodies to shed virus.  
Chicks were hatched from those that did not transmit virus to their embryos based 
on tests on at least three embryos per hen ( Hughes et al., 1963).  
2. Non immune, non virus shedders. Hens without antibodies were selected on 
the assumption that they hade never been infected and were les likely than hens 
with antibodies to become intermittent shedder (Levine an Nelsen., 1964).  
3.  No viremic hen regardless of immune status. These were identified and 
used to provide replacements, how ever up to four generation of testing were 
needed before flocks were free of viremics, and infections of non viremics was not 
ruled out ( Zander et al., 1975).  
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Application of eradication programs of ALV to commercial flock has depended 
on association between virus infections in hens, egg, embryos, and chicks. 
(Spencer et al., 1977).  
A procedure for eradication of ALV involves:  
1. Selection of fertile eggs from hens negative in the egg albumen or vaginal 
swab test (1979; Payne et al., 1982; Crittenden., 1981; Okazaki et al.,1982).  
2. Hatching of chicks in isolation in small groups (25 – 50) in wire – floored 
cages, avoidance of manual vent sexing (Fadly et al., 1981), and of vaccination with 
a common needle (De Boer et al., 1980)  
3. Testing of chicks for ALV by a biologic assay or PCR on blood, discarding 
redactor and contact chicks (Okazaki et al., 1979; Fadly et al., 1981; Okazaki et al., 
1982) 
4. Rearing ALV – free groups in isolation (Fadly et al., 1981; Witter and Fadly., 
2001).           
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CHAPTER TWO 
Materials and methods 
 
2-1 Areas of study 
The areas of study comprised three localities in Khartoum state namely 
Khartoum, Khartoum North and Omdurman. Seventeen farms from these areas 
were targeted for blood collection to detect antibodies against avian leucosis virus 
subgroup J (ALV- J). The flocks of these farms consist of fifteen flocks from 
commercial chicken and two flocks from breeder layers. From each flock 5 – 50 
blood samples were taken based on the flock size. None of the flocks sampled had 
a history of vaccination against ALV-J. Flocks were sampled only once and the 
farms followed an open house system. Totally, 360 blood samples were collected 
from the layer chickens with different ages from several locations in Khartoum state 
as from 15 February through 15 April 2009 (Table 1). The blood sample consisted of 
325 layers, and 35 breeder layers (Table2).  
 
2-2 Collection of blood samples:  
         Blood was collected by veno puncture from the wing vein of the bird using 1ml 
and 2ml disposable syringes and direct from the heart in case of one day old 
chickens. Syringes were then left in a sloping position at room temp over night to 
allow blood to clot. Serum was separated in a labeled eppendorf tubes and kept at – 
20°C until used.  
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Table 1: Location, type of chicken, age, flock size, breed, number of samples 
and history of previous occurring diseases  
Previous 
Diseases 
Number of 
sample 
Breed of 
chickens 
Size of 
flock 
Age of 
chickens 
Type of 
chickens 
Location 
- 10(0. 1%) Bovan 10, 000 16 wks Layer Soba 1 
IBD 15(0. 4%) Hisex 4000 72 wks Layer Soba 2 
IBD 9(0. 15%) Hisex 6000 16 wks Layer Soba 3 
- 10(0. 5%) Hisex 2000 10 wks Layer Dekhenat 1 
IBD 10(0. 3%) Bovan 3500 16 wks Layer Kalakla 1 
- 10(2%) Bovan 500 48 wks Layer Kalakla 2 
- 26(0. 9%) Bovan 3000 4 wks Layer Taiba 1 
salmonella 25(1. 3%) Hisex 2000 40 wks Layer Droshab 1 
- 10(0. 5%) Hisex 2000 36 wks Layer Droshab 2 
- 50(25%) Bovan 200 36 wks Layer Hajyousef 
- 5(0. 12%) Bovan 4000 30 wks Layer Elkabashi 
- 36(1. 2%) Bovan 3000 28 wks Layer Fakihashim 
- 16(1. 1%) Bovan 1500 35 wks Breeder Jablawlia 1 
- 19(0. 5%) Bovan 4000 One day Layer Soba 4 
- 19(0. 9%) Bovan 2000 60 wks Breeder Jablawlia 2 
- 52(1. 7%) Hisex 3000 102 wks Layer Merkhiat 
ND 38(0. 5%) Bovan 7500 16 wks Layer Soba 5 
   
• IBD: infectious Bursal Disease 
• ND: New Castel Disease 
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Table 2: Number of collected blood samples according to chicken type  
Type of chickens Number of samples 
Cmmercial layer 325 
Breeder layer 35 
 
 
2-3 Enzyme linked immune sorbent assay (ELISA):  
    A commercial test kit of ALV-J was used to detect specific antibodies 
against ALV-J based on indirect ELISA, the kit was obtained from pro flock plus 
SYNBIOICS Corporation in USA.  
A serum of 1: 50 dilution was used following the instruction of the manufacturer 
and optical density value was read using an ALISA plate readeing 
spectrophotometer should be 405 – 410 nm.  
 
2-3-1 Materials and reagents provided with the kit:  
ALV-J antigen coated plate.  
ALV-J positive control serum.  
ALV-J negative control serum.  
Goat – anti – chicken – lgG (H+L) peroxides conjugate.  
ABTS – hydrogen peroxides substrate solution.  
Dilution buffer.  
Wash solution.  
Stop solution.  
 
2-3-2 Equipments and materials required in the test:  
High precision single micro titer pipette.  
8 or 12 channels micro titer pipette and disposable tips.  
Two graduated cylinders 50ml.  
Two clean glass tubes.  
Laboratory grade water.  
96 well un coated micro titer plate for serum dilution (serum dilution plate).  
96 well plate reading spectrophotometer with 405 – 410 nm filter.  
Micro titer plate washing apparatus.  
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2-3-3 Sample preparation:  
Serum sample were diluted using dilution buffer in clean un coated 96 micro 
titer plate, frozen serum completely thawed and mixed thoroughly before diluting, 
each serum sample was diluted 1: 50. Positive and negative control wells were 
labeled corresponding to the ALV-J coated plate. 0. 3 ml dilution buffer were added 
to each well of dilution plate except the wells of positive and negative control.  
0. 006ml of un known serum were added per well using a single micro titer 
pipette, each tip was discarded after each sample.  
All diluented sera were allowed to equilibrate in dilution buffer for 5min before 
transferring them to a ALV-J antigen coated plated. 
  
2-3-4 Reagents preparation:  
 All reagents were allowed to come to room temp (22°C – 24°C) before used.  
 
2-3-4-1 Preparation of positive and negative controls:  
  Appropriate volume (0. 006ml) of ALV-J positive control were diluted with 
dilution buffer (0. 3ml) in a clean glass test tube making 1: 50 dilution and mixed 
well, the same was done for negative control.  
 
2-3-4-2 Preparation of wash solution:  
  20ml concentrated wash solution were diluted 380ml laboratory grade water 
(1: 20) to make atotal 400ml solution for each ALV-J micro titer ELISA plate.  
 
2-3-4-3 Preparation of conjugate solution:  
0.1ml stock conjugate were added in 10ml dilution buffer (1: 100), this 
preparation was enough for one 96 well ELISA micro titer plate.  
 
2-3-4-4 Preparation of substrate solution:  
10ml was added for each plate with out dilution  
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2-3-4-5 Preparation of stop solution:  
2. 5ml concentrated stop solutions were diluted in 10ml laboratory grade water 
(1: 5) for each ALV-J coated plate.  
 
2-3-5 Test Procedure:  
An ALV-J antigen coated test plate was removed from the protective sealed 
bag and placed on the clean bench, positive and negative control wells were 
labeled. 0.05ml dilution buffer were added to all wells on the ALV-J test plate using 
12 channels micro titer pipette, tips were discarded. 0.05ml diluted serum samples 
from each well in the dilution plate were taken using 12 channels micro titer pipette 
and added to the ALV-J coated micro titer plate yielding 1: 100 dilution, except wells 
of positive and negative control. Tips were discarded after each raw of diluted 
sample transferred. 0. 05ml ALV-J diluted positive control serum were added to the 
A1, A3, & H11wells, pipette tip was discarded and 0. 05 diluted negative control 
serum were added to A2, H10 and H12 wells, tip was discarded. Tested plate was 
covered by a lid and incubated fore 30min at room temp (22°C – 24°C).  
Plate was allowed to automatic wash for about 3 times, non specific antibodies 
and other serum proteins were washed away, these was take 9mins.  
Plate was inverted and tapped firmly in absorbent paper, to ensure all liquid 
was removed. 0.1ml of prepared anti – chicken – IgG – peroxides conjugate solution 
were added to the test micro titer plate using 12 channels micro titer pipette, tips 
were discarded. Plate was covered with lid and incubated for 30min at room temp 
(22°C – 24°C). Plate was allowed to automatic wash.  Plate was inverted and 
tapped firmly on absorbent paper to ensure all liquid was removed.  
 0.1ml substrate solution were added to each well of tested plate using 12 
channels micro titer pipette, tips were discarded. Tested plate was covered with a lid 
and incubated for 15min at room temp (22°C – 24°C). 0. 1ml diluted stop solution 
was added to each well of the tested plate using 12 channels micro titer pipette to 
stop the reaction.  Light green color was developed in positive wells. Micro titer plate 
spectrophotometer was blanked and the plate was put in the reader, absorbance of 
control and samples were recorded by reading at 405 nm.   
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2-3-6 Interpretation of results  
Valid ALV-J ELISA result were obtained when the average (O. D) value of the 
negative control serum was less than 0. 2 and the corrected positive control value 
range was obtained between (0.25 – 0.9).  
The ALV-J ELISA titer values obtained was represent a comparison of the 
ALV-J antibodies within each field chicken serum tested and the ALV-J ELISA kit 
positive and negative control sera.  
A (0) ALV-J ELISA titer represent a chicken serum samples that contains 
extremely low to insignificance ALV-J antibody level compared to ALV-J ELISA kit 
positive and negative control sera.  
ALV-J ELISA titer obtained above (0) indicate that chicken serum samples 
contains ELISA detectable ALV-J antibody level compared to positive and negative 
control sera.  
 
2-3-7 Manual Processing of Data:  
Calculation of Antibody Titer:  
ALV-J ELISA titer can be calculated by the following equation:  
LOG 10 TITER = (1. 224 × LOG10 SP) + 3. 860  
TITER = ANTILOG OF LOG 10 TITER  
Calculation of S/P ratio:  
Mean of test sample absorbance – Mean of negative control 
Mean of positive control - Mean of negative control 
S/P (sample to positive ratio)  
S/P value Titer range Antibody status 
0.01  or less 2365   or less negative 
0.02   or greater 2366   or more positive 
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CHAPTER THREE 
Results 
 
3-1 Detection of antibodies against ALV-J  
Out of 360 sera sample from a total of 17 flocks 60 (16. 67%) were found 
positive while 300(83. 33%) were proved negative (Table 3).  
In 15 commercial layers flocks, 58(17. 84%) were positive out of 325 serum 
samples whereas 267(82. 16%) were found negative (Table 4).  
Analysis of 35 serum samples taken from, 2 layer breeding flocks, showed 2(5. 
7%) positive samples while, 33(94. 29%) was negative (Table 5).  
The prevalence of antibodies against ALV-J in collected sera was recorded 
according to the age of chicken flocks (Tables 6).  
Different breeds of chicken flocks were evaluated for detection of antibodies 
against ALV-J prevalence of antibodies was recorded (Table 7).  
 
Table 3: Prevalence of antibodies against ALV-J in Khartoum state  
Number of 
samples 
Positive (%) Negative (%) 
360 60(16. 66%) 300(83. 33%) 
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Table 4: Prevalence of antibodies against ALV-J in sera from commercial layer 
in Khartoum state 
Location of 
farm 
Number of 
samples 
Positive 
(%) 
Negative 
(%) 
Soba 1 15 11(73. 33%) 4(26. 66%) 
Soba 2 10 0(0%) 10(100%) 
Soba 3 9 0(0%) 9(100%) 
Dekhenat 1 10 0(0%) 10(100%) 
Kalakla 1 10 2(20%) 8(80%) 
Kalakla 2 10 0(0%) 10(100%) 
Taiba 1 26 0(0%) 26(100%) 
Droshab 1 25 2(8%) 23(92%) 
Droshab 2 10 3(30%) 7(70%) 
Hajyousef 50 19(38%) 31(62%) 
Elkabashi 5 3(60%) 2(40%) 
Fakihashim 36 9(25%) 27(75%) 
Soba 4 19 0(0%) 19(100%) 
Merkhiat 52 5(9. 62%) 47(90. 38%)
Soba 5 38 4(10. 52%) 34(89. 48%)
Total 325 58(17. 84%)
267(82. 
16%) 
 
 
Table 5: Prevalence of antibodies against ALV-J in sera from breeder layer in 
Khartoum state  
Location of 
farm 
Number of 
samples 
Positive (%)
Negative 
(%) 
Jablawlia 1 16 1(6. 25%) 15(93. 75%)
Jablawlia 2 19 1(5. 26%) 18(94. 74%)
Total 35 2(5. 7%) 33(94. 29%)
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Table 6: Prevalence of antibodies against ALV-J according to age  
Negative 
(%) 
Positive (%)
Number of 
samples 
Age of 
chicken 
19(100%) 0(0%) 19 Day one old 
26(100%) 0(0%) 26 4 weeks 
10(100%) 0(0%) 10 10 weeks 
61(91. 05%) 6(8. 95%) 67 16 week 
29(70. 74%) 12(29. 26%) 41 30 week 
53(70. 64%) 23(28. 94%) 76 36 week 
23(92%) 2(8%) 25 40 week 
10(100%) 0(0%) 10 48 week 
18(94. 74%) 1(5. 26%) 19 60 week 
15(100%) 0(0%) 15 72 week 
47(90. 39%) 5(9. 61%) 52 102 week 
 
 
 
Table 7: Prevalence of antibodies against ALV-J in sera according to type of 
breed  
breed Number of samples Positive (%) Negative (%) 
Bovan 239 50(20. 92%) 189(79. 08%) 
Hisex 121 10(8. 26%) 111(91. 74%) 
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Figure 1: The prevalence of antibodies  
A: Sero prevalence of antibodies against ALV-J in different chicken flocks in 
Khartoum state. 
B: Sero prevalence of antibodies against ALV-J in commercial layers in 
Khartoum state. 
C: Sero prevalence of antibodies against ALV-J in breeder layers Khartoum 
state. 
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Figure 2: Sero prevalence of antibodies against ALV-J in different age groups 
of chicken in Khartoum state. 
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 Figure 3: Sero prevalence of antibodies against ALV-J in different breeds in 
Khartoum state. 
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Fig 4: Liver enlargement and white nodules 
Fig 5:Pale comb and paralysis  
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Fig 6: dullness and emaciation 
Fig 7: Blood Sample Collection 
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CHAPTER FOUR 
Discussion 
         Avian Leucosis virus subgroup J (ALV-J) infection has emerged as an 
important disease of chickens responsible for high mortalities and other serious 
implications for poultry industry such as production problems and economic losses 
in broilers in many parts of the world. Broiler chickens were predominately proved to 
be affected by the disease as compared to layer types. This is exemplified by 
reports showed that antibodies against the ALV-J were found in 3 of 5 meat type 
chicken lines but not in 7 layer lines examined in United Kingdom (Payne et al., 
1985). That is pretty true about the disease situations in Sudan where many studies 
detected the infection in broiler chickens. Therefore, it was aimed, in this study, to 
investigate the presence of antibodies (Abs) against ALV-J in both commercial and 
breeder layers of chickens. This seems extremely necessary so as to help in the 
eradication of ALV-J infections from poultry, particularly from breeders since the 
virus is vertically transmitted. 
         In the present study, from the data obtained, it is evident that the disease do 
exist (though to low levels) and spreading among both types of flocks investigated. 
It was also observed that antibodies against the causative virus were detected in the 
breeder layers of chickens. This can allow us to address the fact that It is important 
to note that the presence of ALV-J in the layer breeder can lead to risk of ALV-J 
infection in their progeny by vertical transmission. It was previously reported that 
over 90% of the virus positive embryos which produced from hens infected with 
ALV-J between 29-34 weeks of age under experimental condition (Witter et al., 
2000). 
         In Sudan, ALV-J infection was reported in a broiler parent farm in Khartoum 
state using the polymerase chain reaction (PCR) to detect the virus in the liver and 
spleen (Maaz and Abdelmelik, 2005). These results provide evidence that the 
disease caused heavy losses in the broiler parent stock was cause by three avian 
leucosis subgroups (ALV subgroup A-D, HPRS and ALV-J).  
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         In this study, the result obtained for detection of antibodies against ALV-J in 
one day old sera showed negative results when the indirect ELISA system was 
employed. However, in another study by Arafa et al.  (2007) the virus had been 
detected using PCR to detect ALV-J proviral DNA in blood, and ELISA for detection 
of ALV-J antibodies in serum also ELISA used to detect P27 anti gene in meconia. 
Meyers and Dougherty (1972) and Meyers (1976) noticed that chicken that infected 
congenitally by ALV do not develop immune response to the virus, and develop a 
persistent viremia in the absence of neutralizing antibodies. Rup et al. (1982) also 
reported that infection by ALV can depress primary and secondary antibody 
responses and cell – mediated immunity as well. 
         These findings indicate that the age of exposure plays an important role in 
outcome of infection, birds exposed to the virus at younger age tend to develop 
tolerant viremia, while exposure at an older age lead to immune bird may or the bird 
may not shed the virus. (Venugopal., 1999). 
         The positive ALV-J antibody results obtained in this study is attributed to the 
exposure of chickens to gp85 protein of ALV-J based on the antigen used to coat 
the plate of ELISA system adopted. This had previously been published by Fuch et 
al. (2000) so that it is important to consider that test that detect antigens of ALV-J, 
such as ELISA may not be specific enough because of the differences of the 
epitopic proteins of the virus serotype incriminated in the disease the among ALV- 
groups (Payne et al, 1993; Vanugopal et al, 1998; Smith et al, 1999; Fadly and 
Smith, 1999; Silva et al, 2000). Recently polymerase chain reaction (PCR) assay & 
RT-PCR test have also been developed for the detection ALV-J proviral DNA and 
viral RNA in infected materials. However, the sensitivity of PCR is still controversial 
(Smith et al, 1998), and further development and evaluation of PCR test as method 
for detecting ALV-J infections are required (Payne, 1998). 
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Conclusions 
From the findings obtained in the present study, the following conclusive 
points can emerge: 
1- Antibodies against ALV-J were detected in layers type of chickens in 
Khartoum. 
2- All chickens in different locations of the state investigated showed low 
prevalence of antibodies against ALV-J. 
3- No age susceptibility preference in infectivity with ALV-J. 
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  Recommendations  
• Further investigations to determine the disease spread among other flocks in 
different localities using more broad spectrum serological and molecular techniques 
should be followed. 
• Knowledge about the disease epidemiology and pathology should disseminated 
even among the farmers. This could help in the disease control and eradications 
programs 
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